Biogen (BIIB) option implied volatility increases

Biogen (NASDAQ: BIIB) October weekly call option implied volatility is at 30, October is at 27, November is at 66; compared to its 52-week range of 25 to 63 into a FDA panel to discuss Biogen Alzheimer's application on November 6. Call put ratio 1.6 calls to 1 put with focus on October and January options.

You May Also Be Interested In

• Biogen (BIIB) PT Lowered to $270 at Oppenheimer
• Zions Bancorp (ZION) April weekly option implied volatility into quarter results
• NVIDIA (NVDA) option implied volatility as share price down 1%